Amplifying the Patient Voice: Reflections from MAPS EMEA 2025
At this year’s MAPS EMEA 2025 Annual Meeting in London, the message was clear: the patient voice is central to every stage of the drug development journey, a theme eloquently showcased in the Opening General Assembly: Patient Impact on Medical Affairs. Global leaders in Medical Affairs gathered to explore how the industry can evolve from…...
Read MoreTop Stories
What’s Next for Global Capability Centers )?
The theme for this year’s NASSCOM GCC Summit, “The Next GCC...
MAPS 2025 Decoded: The Medical Affairs Playbook
At the MAPS Americas 2025 conference in New Orleans, one of...
Medical Affairs 2.0: GenAI as the Catalyst for
Digital and AI were hot topics underpinning many of the...
Filter
Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence
As global biopharma companies face rising demands for efficiency, standardization, and scientific excellence, Global Capability...
What’s Next for Global Capability Centers (GCCs)? Cactus Life Sciences at the NASSCOM GCC Summit 2025
The theme for this year’s NASSCOM GCC Summit, “The Next GCC Frontier: Ambition, Agility, Ascent,”...
Medical Affairs 2.0: GenAI as the Catalyst for Change in Writing, MedComms, and Field Strategy
Digital and AI were hot topics underpinning many of the conversations at the DIA’s Medical...
Biopharma Trends 2025: 3 Things to Know Right Now
The global business climate is ever-evolving, and 2025 looks like it may be particularly challenging...
Science, AI, and Human Ingenuity Converge to Transform Medical Affairs
Today, we're witnessing an unprecedented convergence of scientific advancement, artificial intelligence (AI) capabilities, and human...
Key Solution Guide: Empowering Medical Affairs by Leveraging Modular Content
In the biopharma sector, the overwhelming influx of medical data necessitates an efficient content strategy...